0001104659-20-135400.txt : 20201214
0001104659-20-135400.hdr.sgml : 20201214
20201214203318
ACCESSION NUMBER: 0001104659-20-135400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Rajeev M.
CENTRAL INDEX KEY: 0001619841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 201387891
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences Inc.
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 900943402
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-337-4680
MAIL ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Solid Biosciences, LLC
DATE OF NAME CHANGE: 20170524
4
1
tm2038490-1_form4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-10
0
0001707502
Solid Biosciences Inc.
SLDB
0001619841
Shah Rajeev M.
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON
MA
02116
1
0
1
0
Common Stock
2020-12-10
4
A
0
4938282
3.70
A
8709882
I
See footnote
The securities reported on this Form 4 exclude 799,564 shares held in an account owned by a separately managed account (the "Account") that were reported on the previous Form 4 filed by Mr. Shah. RA Capital Management, L.P. (the "Adviser") is the investment adviser of the Account. The shares held by the Account have been excluded from the securities reported on this Form 4 pursuant to Rule 16a-1(a)(2)(ii)(C).
The Adviser is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The filing of this Form 4 shall not be construed as an admission that Mr. Shah is or was for the purposes of Section 16(a), or otherwise, the beneficial owner of the reported securities, and he disclaims beneficial ownership of the reported securities except to the extent of any pecuniary interest.
/s/ Rajeev Shah, individually
2020-12-14